Cargando…

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World

Detalles Bibliográficos
Autores principales:	Greenhawt, Matthew, Abrams, Elissa M., Oppenheimer, John, Vander Leek, Timothy K., Mack, Douglas P., Singer, Alexander G., Shaker, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847187/ https://www.ncbi.nlm.nih.gov/pubmed/33529722 http://dx.doi.org/10.1016/j.jaip.2021.01.022

Ejemplares similares

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2021)

A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
por: Shaker, Marcus, et al.
Publicado: (2021)

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2019)

Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
por: Shaker, Marcus S., et al.
Publicado: (2022)

Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020)

What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care
por: Abrams, Elissa M., et al.
Publicado: (2021)

The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

School Attendance, Asthma Risk, and COVID-19 in Children
por: Abrams, Elissa M., et al.
Publicado: (2021)

COVID-19 and the importance of effective risk communication with children
por: Abrams, Elissa M, et al.
Publicado: (2022)

Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
por: Abrams, Elissa M., et al.
Publicado: (2021)

Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care
por: Greenhawt, Matthew, et al.
Publicado: (2020)

COVID-19 vaccines: addressing hesitancy in young people with allergies
por: Abrams, Elissa M, et al.
Publicado: (2021)

The COVID-19 pandemic: Adverse effects on the social determinants of health in children and families
por: Abrams, Elissa M., et al.
Publicado: (2022)

Anaphylaxis
por: Fischer, David, et al.
Publicado: (2018)

Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change
por: Mack, Douglas P., et al.
Publicado: (2020)

An avoidable cause of thymoglobulin anaphylaxis
por: Brabant, S., et al.
Publicado: (2017)

Mitigating Misinformation and Changing the Social Narrative
por: Abrams, Elissa M., et al.
Publicado: (2020)

Risk Communication During COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

Anaphylaxis related to avocado ingestion: a case and review
por: Abrams, Elissa M, et al.
Publicado: (2011)

Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?
por: Warren, Ruth, et al.
Publicado: (2006)

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening
por: Paci, Eugenio, et al.
Publicado: (2005)

Anaphylaxie-Leitlinie: Update 2021
por: Ring, Johannes, et al.
Publicado: (2021)

ICEER 2021: Developing the World in 2021 with clean and safe energy
por: Caetano, Nídia S., et al.
Publicado: (2022)

Anaphylaxis avoidance and management: educating patients and their caregivers
por: Järvinen, Kirsi M, et al.
Publicado: (2014)

Biphasic anaphylaxis: a systematic review of the literature
por: Mack, Douglas P
Publicado: (2014)

A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services
por: Searing, Daniel A., et al.
Publicado: (2020)

Primum non nocere—first do no harm. And then feed peanut
por: Hildebrand, Kyla Jade, et al.
Publicado: (2017)

Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature
por: Kovaltchouk, Uliana, et al.
Publicado: (2023)

Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2018)

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019)

Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction
por: Greenhawt, Matthew, et al.
Publicado: (2019)

On the Social Construction of Overdiagnosis: Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine"
por: Hofmann, Bjørn
Publicado: (2017)

Chloramine-induced anaphylaxis while showering: a case report
por: D’Alò, Simona, et al.
Publicado: (2012)

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening
por: Moss, Sue
Publicado: (2005)

Overdiagnosis of breast cancer in Denmark
por: Zahl, P-H
Publicado: (2004)

Overdiagnosis and breast cancer screening
por: Day, Nick E
Publicado: (2005)

Overuse, Overdose, Overdiagnosis… Overreaction?
por: Ho, ELM
Publicado: (2010)

Overdiagnosis: epidemiologic concepts and estimation
por: Bae, Jong-Myon
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ohmcejdtnrcv26qto5hd9cpeja